DCF — WILLIAMSON HEALTH
Enterprise Value: $-174.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-174.8M
Enterprise Value
$-61.0M
PV of Cash Flows
$-113.8M
PV of Terminal Value
$-183.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $279.5M | $-7.8M | -3.0% | $-19.6M | $-17.8M |
| Year 2 | $287.9M | $-5.1M | -2.0% | $-17.3M | $-14.3M |
| Year 3 | $296.6M | $-2.3M | -1.0% | $-14.9M | $-11.2M |
| Year 4 | $305.5M | $-0.8M | -0.0% | $-13.8M | $-9.4M |
| Year 5 | $314.6M | $-0.1M | -0.0% | $-13.4M | $-8.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-174.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$271.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.032776902622933854
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5